Hydrocortisone with miconazole

Elderly: natural thinning of the skin occurs, so corticosteroids should be used sparingly and for short periods of time. Do not use if the skin is broken, on large areas of skin, for longer than 7 days, to treat cold sores or acne, on the face, eyes or mucous membranes, in children under 10 years of age unless prescribed by a doctor, on the ano-genital region unless prescribed by a doctor, to treat ringworm unless prescribed by a doctor, or to treat secondarily infected conditions unless prescribed by a doctor (§4.3). Must not come into contact with the mucosa of the eyes. Caution when applying to extensive surface areas or under occlusive dressings including baby napkins; avoid application to the face. Long-term continuous topical corticosteroid therapy should be avoided — adrenal suppression can occur even without occlusion. Once the inflammatory conditions have disappeared, treatment may be continued with miconazole alone (cream or powder). Discontinue if a reaction suggesting hypersensitivity or irritation occurs. Avoid contact with latex products such as contraceptive diaphragms or condoms, which may be damaged by the cream; cotton underwear is recommended where clothing contacts the treated area. Report blurred vision or other visual disturbance for ophthalmological evaluation (cataract, glaucoma, central serous chorioretinopathy). Contains benzoic acid (E210) 2 mg/g, which may cause local irritation, and butylhydroxyanisole (E320) 0.052 mg/g, which may cause local skin reactions. PAEDIATRIC: no paediatric dose is given in this SPC; the product is not to be used in children under 10 years of age unless prescribed by a doctor. Verify paediatric use against a children's formulary. Source: eMC SPC for Daktacort Hydrocortisone Cream (§4.2) — a fixed combination of hydrocortisone with miconazole, so the source covers both components. The openFDA record in this bundle is an unrelated OTC topical 'anti itch' hydrocortisone product and was not used.